Natural Capsules Quarterly Results for Trading Insights
In Mar 2026, Natural Capsules (NATCAPSUQ) reported revenue ₹59 Cr and net profit ₹-5 Cr — revenue +31.1% YoY. Browse NATCAPSUQ income statement for revenue, profit, balance sheet and cash flow data.
NATCAPSUQ Quarterly Results — Revenue, Profit & EPS Highlights
Natural Capsules latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Natural Capsules share price today.
- Revenue of ₹59 Cr in Mar 2026 (+28.3% vs Sept 2025, +31.1% vs Mar 2025)
- Net Profit of ₹-5 Cr in Mar 2026 (+28.6% vs Sept 2025, -600.0% vs Mar 2025)
- EBITDA of ₹2 Cr in Mar 2026 (+300.0% vs Sept 2025)
- Operating Margin of 2.0% in Mar 2026 (+4.0pp vs Sept 2025)
- Earnings Per Share of ₹-4.82 in Mar 2026 (+28.7% vs Sept 2025)
Natural Capsules Quarterly Results — Revenue, EBITDA, Net Profit & EPS
NATCAPSUQ quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 59 | 46 | 45 | 46 | 38 | 28.3% | 31.1% |
| Net Profit (₹ Cr) | -5 | -7 | 1 | -6 | -7 | - | - |
| EBITDA (₹ Cr) | 2 | -1 | 5 | 1 | -2 | - | - |
| EPS (₹) | -4.82 | -6.76 | 0.13 | -5.40 | -6.88 | - | - |
| Operating Margin (%) | 2.0% | -2.0% | 10.0% | 1.0% | -6.0% | - | - |
NATCAPSUQ Share Price Trend — 1-Year Movement Across Quarterly Results
Natural Capsules 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore NATCAPSUQ stock price history to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
NATCAPSUQ vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Natural Capsules latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹457,721.13 Cr | 1912.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 169.3 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6857.5 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 242.2 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4822.7 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 419.0 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1472.3 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 214.3 |
|
Zydus Life Science
Mar 2026 |
₹115,505.60 Cr | 1147.9 | 7,569 | 1,341 | +23.1% | +18.8% | 17.7% | 90.7 |
All amounts in ₹ Crores